Incidence and clinical significance of 6q deletions in B cell chronic lymphocytic leukemia

Leukemia

Volumn 13, Issue 9, 1999, Pages 1331-1334

  Stilgenbauer, S ^a   Bullinger, L ^a   Banner, A ^b   Wildenberger, K ^a   Bentz, M ^a   Dohner K ^a   Ho, A D ^a   Lichter, P ^b   Dohner H ^a,c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c Medizinische Klinik und Poliklinik V   (Germany)

Author keywords

6q deletion; B CLL; FISH; Lymphadenopathy; Prognostic factor

Indexed keywords

ARTICLE; B CELL LEUKEMIA; CHROMOSOME 6Q; CHROMOSOME DELETION; CHROMOSOME MAP; CHRONIC LYMPHATIC LEUKEMIA; CLONE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; TUMOR SUPPRESSOR GENE; YEAST ARTIFICIAL CHROMOSOME;

EID: 0032845683     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401499     Document Type: Article

References (25)

1. Bloomfield CD, Arthur DC, Frizzera G, Levine EG, Peterson BA, Gajl-Peczalska KJ. Nonrandom chromosome abnormalities in lymphoma. Cancer Res 1983; 43: 2975-2984.
2. Johansson B, Mertens F, Mitelman F. Cytogenetic deletion maps of hematologic neoplasms: circumstantial evidence for tumor suppressor loci. Genes Chrom Cancer 1993; 8: 205-218.
3. Gaidano G, Hauptschein RS, Parsa NZ, Offit K, Rao PH, Lenoir G, Knowles DM, Chaganti RSK, Dalla-Favera R. Deletions involving two distinct regions of 6q in B cell non-Hodgkin lymphoma. Blood 1992; 80: 1781-1787.
4. Guan XY, Horsman D, Zhang HE, Parsa NZ, Meltzer PS, Trent JM. Localization by chromosome microdissection of a recurrent breakpoint region on chromosome 6 in human B-cell lymphoma. Blood 1996; 88: 1418-1422.
5. Offit K, Parsa NZ, Gaidano G, Filippa DA, Louie D, Pan D, Jhanwar SC, Dalla-Favera R, Chaganti RSK. 6q deletions define distinct clinico-pathologic subsets of non-Hodgkin's lymphoma. Blood 1993; 82: 2157-2162.
6. Offit K, Louie DC, Parsa NZ, Filippa D, Gangi M, Siebert R, Chaganti RSK. Clinical and morphologic features of B-cell small lymphocytic lymphoma with del(6)(q21q23). Blood 1994; 83: 2611-2618.
7. Juliusson G, Oscier D, Gahrton G for the International Working Party on Chromosomes in CLL (IWCCLL). Cytogenetic findings and survival in B-cell chronic lymphocytic leukemia. Second IWCCLL compilation of data on 662 patients. Leuk Lymphoma 1991; 5: 21-25.
8. Stilgenbauer S, Döhner K, Bentz M, Lichter P, Döhner H. Molecular cytogenetic analysis of B-cell chronic lymphocytic leukemia. Ann Hematol 1998; 76: 101-110.
9. Zhang Y, Weber-Matthiesen K, Siebert R, Matthiesen P, Schlegelberger B. Frequent deletions of 6q23-24 in B-cell non-Hodgkin's lymphomas detected by fluorescence in situ hybridization. Genes Chrom Cancer 1997; 18: 310-313.
10. Tilly H, Rossi A, Stamatoullas A, Lenormand B, Bigorgne C, Kunlin A, Monconduit M, Bastard C. Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood 1994; 84: 1043-1049.
11. Whang-Peng J, Knutsen T, Jaffe ES, Steinberg SM, Raffeld M, Zhao WP, Duffey P, Condron K, Yano T, Longo DL. Sequential analysis of 43 patients with non-Hodgkin's lymphoma: clinical correlations with cytogenetic, histologic, immunophenotyping, and molecular studies. Blood 1995; 85: 203-216.
12. Oscier DG, Stevens J, Hamblin TJ, Pickering RM, Lambert R, Fitchett M. Correlation of chromosome abnormalities with laboratory features and clinical course in B-cell chronic lymphocytic leukaemia. Br J Haematol 1990; 76: 352-358.
13. Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O'Brien S, Rai KR. National Cancer Institute-Sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996; 87: 4990-4997.
14. Döhner H, Stilgenbauer S, James MR, Benner A, Bentz M, Fischer K, Hunstein W, Lichter P. 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood 1997; 89: 2516-2522.
15. Döhner H, Pohl S, Bulgay-Mörschel M, Stilgenbauer S, Bentz M, Lichter P. Detection of trisomy 12 in chronic lymphoid leukemias using fluorescence in situ hybridization. Leukemia 1993; 7: 516-520.
16. Stilgenbauer S, Döhner H, Bulgay-Mörschel M, Weitz S, Bentz M, Lichter P. High frequency of monoallelic retinoblastoma gene deletion in B-cell chronic lymphoid leukemia shown by interphase cytogenetics. Blood 1993; 81: 2118-2124.
17. Lichter P, Bentz M, Joos S. Detection of chromosomal aberrations by means of molecular cytogenetics: painting of chromosomes and chromosomal subregions and comparative genomic hybridization. Meth Enzymol 1995; 254: 334-359.
18. Lengauer C, Green ED, Cremer T. Fluorescence in situ hybridization of YAC clones after Alu-PCR amplification. Genomics 1992; 13: 826-828.
19. Hauptschein RS, Gamberi B, Rao PH, Frigeri F, Scotto L, Venkatraj VS, Gaidano G, Rutner T, Edwards YH, Chaganti RSK, Dalla-Favera R. Cloning and mapping of human chromosome 6q26-q27 deleted in B-cell non-Hodgkin lymphoma and multiple tumor types. Genomics 1998; 50: 170-186.
20. Merup M, Moreno TC, Heyman M, Rönnberg K, Grandér D, Detlofsson R, Rasool O, Liu Y, Söderhäll S, Juliusson G, Gahrton G, Einhorn S. 6q deletions in acute lymphoblastic leukemia and non-Hodgkin's lymphomas. Blood 1998; 91: 3397-4000.
21. Sherratt T, Moreili C, Boyle JM, Harrison CJ. Analysis of chromo-some 6 deletions in lymphoid malignancies provides evidence for a region of minimal deletion within a 2-megabase segment of 6q21. Chrom Res 1997; 5: 118-124.
22. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. Wiley: New York, 1980.
23. Cox DR. Regression models and life tables (with discussion). J Roy Stat Soc (B) 1972; 34: 187-220.
24. Gaidano G, Newcomb EW, Gong JZ, Tassi V, Neri A, Cortelezzi A, Calori R, Baldini L, Dalla-Favera R. Analysis of alterations of oncogenes and tumor suppressor genes in chronic lymphocytic leukemia. Am J Pathol 1994; 144: 1312-1319.
25. Jackson A, Panayiotidis P, Foroni L. The human homologue of the drosophila tailless gene (TLX): characterization and mapping to a region of common deletion in human lymphoid leukemia on chromosome 6q21. Genomics 1998; 50: 34-40.